M&A Deal Summary

Merck Acquires Schering-Plough

On November 3, 2009, Merck acquired life science company Schering-Plough for 41.1B USD

Acquisition Highlights
  • This is Merck’s 7th transaction in the Life Science sector.
  • This is Merck’s largest (disclosed) transaction.
  • This is Merck’s 7th transaction in the United States.
  • This is Merck’s 2nd transaction in New Jersey.

M&A Deal Summary

Date 2009-11-03
Target Schering-Plough
Sector Life Science
Buyer(s) Merck
Deal Type Add-on Acquisition
Deal Value 41.1B USD

Target

Schering-Plough

Kenilworth, New Jersey, United States
website
Schering-Plough Corp. is a manufacturer and sells pharmaceuticals.

Search 193,724 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Merck

Rahway, New Jersey, United States

website


Category Company
Founded 1891
Sector Life Science
Employees67,000
Revenue 59.3B USD (2022)
DESCRIPTION
Merck office in Palo Alto, California.
Merck office in Palo Alto, California.

Merck is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. The Company’s operations are comprised of four operating segments. These include Pharmaceutical, Animal Health, Consumer Care and Alliances. Merck's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The Company also has animal health operations that discover, develop, manufacture and market animal health products, including vaccines, which the Company sells to veterinarians, distributors and animal producers. Additionally, the Company has consumer care operations that develop, manufacture and market over-the-counter, foot care and sun care products. Merck was established in 1891 and is based in Rahway, New Jersey.


DEAL STATS #
Overall 8 of 32
Sector (Life Science) 7 of 29
Type (Add-on Acquisition) 8 of 31
State (New Jersey) 2 of 3
Country (United States) 7 of 26
Year (2009) 1 of 1
Size (of disclosed) 1 of 26
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-07-30 Merial

Duluth, Georgia, United States

Merial Ltd. is an animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals.

Sell $4.0B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2010-12-02 SmartCells

Beverly, Massachusetts, United States

SmartCells, Inc. is focused on developing glucose-regulated SmartInsulin products for the treatment of diabetes mellitus.

Buy $500M